SMTL ID : 2uzw.1

PKA structures of indazole-pyridine series of AKT inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x SS4: 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE(Non-covalent)

SS4.1: 18 residues within 4Å: Chain A: L.35, G.36, T.37, G.38, G.41, V.43, A.56, K.58, M.106, E.107, Y.108, V.109, E.156, N.157, L.159, T.169, D.170, F.313 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.35, A:V.43, A:L.159, A:T.169, A:F.313 Hydrogen bonds: A:E.107, A:V.109, A:N.157, A:D.170, A:D.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, G.D. et al., Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced Hypotension. J.Med.Chem. (2007)

Release Date

2007-06-05

Peptides

CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT: A
CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
I

CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT

CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA

Related Entries With Identical Sequence